Cargando…
Pharmacological Blockade of NLRP3 Inflammasome/IL-1β-Positive Loop Mitigates Endothelial Cell Senescence and Dysfunction
The clinical relevance of IL-1β in chronic inflammation underlying atherosclerosis has been reinforced by recent evidence associating pharmacological inhibition of the cytokine with lower cardiovascular risk. Previously, we have demonstrated a direct involvement of IL-1β in endothelial senescence. T...
Autores principales: | Romero, Alejandra, Dongil, Pilar, Valencia, Inés, Vallejo, Susana, Hipólito-Luengo, Álvaro San, Díaz-Araya, Guillermo, Bartha, José L, González-Arlanzón, María M, Rivilla, Fernando, de la Cuesta, Fernando, Sánchez-Ferrer, Carlos F, Peiró, Concepción |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782550/ https://www.ncbi.nlm.nih.gov/pubmed/35111374 http://dx.doi.org/10.14336/AD.2021.0617 |
Ejemplares similares
-
NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically
por: González-Moro, Ainara, et al.
Publicado: (2022) -
Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome
por: Romacho, Tania, et al.
Publicado: (2020) -
The angiotensin‐(1‐7)/Mas receptor axis protects from endothelial cell senescence via klotho and Nrf2 activation
por: Romero, Alejandra, et al.
Publicado: (2019) -
The Angiotensin-(1-7)/Mas Axis Counteracts Angiotensin II-Dependent and -Independent Pro-inflammatory Signaling in Human Vascular Smooth Muscle Cells
por: Villalobos, Laura A., et al.
Publicado: (2016) -
Inhibition of NLRP3 inflammasome activation by cell-permeable stapled peptides
por: Pal, Arumay, et al.
Publicado: (2019)